{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:54:52Z","timestamp":1790398492360,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG066597"],"award-info":[{"award-number":["P01AG066597"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG066597"],"award-info":[{"award-number":["P01AG066597"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG066597"],"award-info":[{"award-number":["P01AG066597"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG066597"],"award-info":[{"award-number":["P01AG066597"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG066597"],"award-info":[{"award-number":["P01AG066597"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG010124"],"award-info":[{"award-number":["P01AG010124"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG010124"],"award-info":[{"award-number":["P01AG010124"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG010124"],"award-info":[{"award-number":["P01AG010124"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54NS115322"],"award-info":[{"award-number":["U54NS115322"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AG062418"],"award-info":[{"award-number":["U19AG062418"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AG062418"],"award-info":[{"award-number":["U19AG062418"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AG062418"],"award-info":[{"award-number":["U19AG062418"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS095792"],"award-info":[{"award-number":["R01NS095792"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56AG063344"],"award-info":[{"award-number":["R56AG063344"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are neuropathologic subtypes of frontotemporal lobar degeneration with tau inclusions (FTLD-tau), primary tauopathies in which intracellular tau aggregation contributes to neurodegeneration. Gosuranemab (BIIB092) is a humanized monoclonal antibody that binds to N-terminal tau. While Gosuranemab passive immunotherapy trials for PSP failed to demonstrate clinical benefit, Gosuranemab reduced N-terminal tau in the cerebrospinal fluid of transgenic mouse models and PSP patients. However, the neuropathologic sequelae of Gosuranemab have not been described. In this present study, we examined the brain tissue of three individuals who received Gosuranemab. Post-mortem human brain tissues were studied using immunohistochemistry to identify astrocytic and microglial differences between immunized cases and a cohort of unimmunized PSP, CBD and aging controls. Gosuranemab immunotherapy was not associated with clearance of neuropathologic FTLD-tau inclusions. However, treatment-associated changes were observed including the presence of perivascular vesicular astrocytes (PVA) with tau accumulation within lysosomes. PVAs were morphologically and immunophenotypically distinct from the tufted astrocytes seen in PSP, granular fuzzy astrocytes (GFA) seen in aging, and astrocytic plaques seen in CBD. Additional glial responses included increased reactive gliosis consisting of bushy astrocytosis and accumulation of rod microglia. Together, these neuropathologic findings suggest that Gosuranemab may be associated with a glial response including accumulation of tau within astrocytic lysosomes.<\/jats:p>","DOI":"10.1007\/s00401-021-02318-y","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T04:03:05Z","timestamp":1620187385000},"page":"243-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Tau immunotherapy is associated with glial responses in FTLD-tau"],"prefix":"10.1007","volume":"142","author":[{"given":"Boram","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey","family":"Mikytuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunran","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett S.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivianna M.","family":"Van Deerlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev N.","family":"Vaishnavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith A.","family":"Spindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Massimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Q.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-1180","authenticated-orcid":false,"given":"Edward B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"2318_CR1","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1038\/s41598-019-41105-4","volume":"9","author":"CR Andersson","year":"2019","unstructured":"Andersson CR, Falsig J, Stavenhagen JB, Christensen S, Kartberg F, Rosenqvist N, Finsen B, Pedersen JT (2019) Antibody-mediated clearance of tau in primary mouse microglial cultures requires Fc\u03b3-receptor binding and functional lysosomes. Sci Rep 9:4658. https:\/\/doi.org\/10.1038\/s41598-019-41105-4","journal-title":"Sci Rep"},{"key":"2318_CR2","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","volume":"27","author":"AA Asuni","year":"2007","unstructured":"Asuni AA, Boutajangout A, Quartermain D, Sigurdsson EM (2007) Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci 27:9115\u20139129. https:\/\/doi.org\/10.1523\/JNEUROSCI.2361-07.2007","journal-title":"J Neurosci"},{"key":"2318_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40478-015-0209-z","volume":"3","author":"AD Bachstetter","year":"2015","unstructured":"Bachstetter AD, Van Eldik LJ, Schmitt FA, Neltner JH, Ighodaro ET, Webster SJ, Patel E, Abner EL, Kryscio RJ, Nelson PT (2015) Disease-related microglia heterogeneity in the hippocampus of Alzheimer\u2019s disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathol Commun 3:32. https:\/\/doi.org\/10.1186\/s40478-015-0209-z","journal-title":"Acta Neuropathol Commun"},{"key":"2318_CR4","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG et al (2017) QuPath: Open source software for digital pathology image analysis. Sci Rep 7:16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5","journal-title":"Sci Rep"},{"key":"2318_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1474-4422(19)30139-5","volume":"18","author":"AL Boxer","year":"2019","unstructured":"Boxer AL, Qureshi I, Ahlijanian M, Grundman M, Golbe LI, Litvan I, Honig LS, Tuite P, McFarland NR, O\u2019Suilleabhain P et al (2019) Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial. Lancet Neurol 18:549\u2013558. https:\/\/doi.org\/10.1016\/S1474-4422(19)30139-5","journal-title":"Lancet Neurol"},{"key":"2318_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2014.09.007","volume":"36","author":"J Bright","year":"2015","unstructured":"Bright J, Hussain S, Dang V, Wright S, Cooper B, Byun T, Ramos C, Singh A, Parry G, Stagliano N et al (2015) Human secreted tau increases amyloid-beta production. Neurobiol Aging 36:693\u2013709. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.09.007","journal-title":"Neurobiol Aging"},{"issue":"Suppl 1","key":"2318_CR7","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.3233\/jad-132477","volume":"40","author":"DL Castillo-Carranza","year":"2014","unstructured":"Castillo-Carranza DL, Gerson JE, Sengupta U, Guerrero-Mu\u00f1oz MJ, Lasagna-Reeves CA, Kayed R (2014) Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds. J Alzheimers Dis 40(Suppl 1):S97-s111. https:\/\/doi.org\/10.3233\/jad-132477","journal-title":"J Alzheimers Dis"},{"key":"2318_CR8","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1523\/jneurosci.3192-13.2014","volume":"34","author":"DL Castillo-Carranza","year":"2014","unstructured":"Castillo-Carranza DL, Sengupta U, Guerrero-Mu\u00f1oz MJ, Lasagna-Reeves CA, Gerson JE, Singh G, Estes DM, Barrett AD, Dineley KT, Jackson GR et al (2014) Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. J Neurosci 34:4260\u20134272. https:\/\/doi.org\/10.1523\/jneurosci.3192-13.2014","journal-title":"J Neurosci"},{"key":"2318_CR9","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1093\/brain\/awu213","volume":"137","author":"L Collin","year":"2014","unstructured":"Collin L, Bohrmann B, Gopfert U, Oroszlan-Szovik K, Ozmen L, Gruninger F (2014) Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer\u2019s disease. Brain 137:2834\u20132846. https:\/\/doi.org\/10.1093\/brain\/awu213","journal-title":"Brain"},{"key":"2318_CR10","doi-asserted-by":"publisher","first-page":"fcaa039","DOI":"10.1093\/braincomms\/fcaa039","volume":"2","author":"V Corsetti","year":"2020","unstructured":"Corsetti V, Borreca A, Latina V, Giacovazzo G, Pignataro A, Krashia P, Natale F, Cocco S, Rinaudo M, Malerba F et al (2020) Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer\u2019s disease models. Brain Commun 2:fcaa039. https:\/\/doi.org\/10.1093\/braincomms\/fcaa039","journal-title":"Brain Commun"},{"key":"2318_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay8826","author":"NF Darwich","year":"2020","unstructured":"Darwich NF, Phan JM, Kim B, Suh E, Papatriantafyllou JD, Changolkar L, Nguyen AT, O\u2019Rourke CM, He Z, Porta S et al (2020) Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau. Science. https:\/\/doi.org\/10.1126\/science.aay8826","journal-title":"Science"},{"key":"2318_CR12","first-page":"135","volume":"20","author":"DW Dickson","year":"2011","unstructured":"Dickson DW, Hauw JJ, Agid Y, Litvan I (2011) Progressive supranuclear palsy and corticobasal degeneration. Neurodegeneration: the molecular pathology of dementia and movement disorders. Offl J Movement Disord Soc 20:135\u2013155","journal-title":"Offl J Movement Disord Soc"},{"key":"2318_CR13","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/brain\/awm032","volume":"130","author":"LI Golbe","year":"2007","unstructured":"Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130:1552\u20131565. https:\/\/doi.org\/10.1093\/brain\/awm032","journal-title":"Brain"},{"key":"2318_CR14","doi-asserted-by":"publisher","first-page":"33081","DOI":"10.1074\/jbc.M113.494922","volume":"288","author":"J Gu","year":"2013","unstructured":"Gu J, Congdon EE, Sigurdsson EM (2013) Two novel Tau antibodies targeting the 396\/404 region are primarily taken up by neurons and reduce Tau protein pathology. J Biol Chem 288:33081\u201333095. https:\/\/doi.org\/10.1074\/jbc.M113.494922","journal-title":"J Biol Chem"},{"key":"2318_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00401-014-1380-1","volume":"129","author":"DJ Irwin","year":"2015","unstructured":"Irwin DJ, Cairns NJ, Grossman M, McMillan CT, Lee EB, Van Deerlin VM, Lee VM, Trojanowski JQ (2015) Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol 129:469\u2013491. https:\/\/doi.org\/10.1007\/s00401-014-1380-1","journal-title":"Acta Neuropathol"},{"key":"2318_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/alzrt278","volume":"6","author":"E Kontsekova","year":"2014","unstructured":"Kontsekova E, Zilka N, Kovacech B, Novak P, Novak M (2014) First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer\u2019s disease model. Alzheimers Res Ther 6:44. https:\/\/doi.org\/10.1186\/alzrt278","journal-title":"Alzheimers Res Ther"},{"key":"2318_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrneurol.2011.43","volume":"7","author":"N Kouri","year":"2011","unstructured":"Kouri N, Whitwell JL, Josephs KA, Rademakers R, Dickson DW (2011) Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol 7:263\u2013272. https:\/\/doi.org\/10.1038\/nrneurol.2011.43","journal-title":"Nat Rev Neurol"},{"key":"2318_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B et al (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87\u2013102. https:\/\/doi.org\/10.1007\/s00401-015-1509-x","journal-title":"Acta Neuropathol"},{"key":"2318_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, Coughlin D, Giese A, Grossman M, Kurz C et al (2020) Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140:99\u2013119. https:\/\/doi.org\/10.1007\/s00401-020-02158-2","journal-title":"Acta Neuropathol"},{"key":"2318_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-018-0552-y","volume":"6","author":"GG Kovacs","year":"2018","unstructured":"Kovacs GG, Xie SX, Robinson JL, Lee EB, Smith DH, Schuck T, Lee VM, Trojanowski JQ (2018) Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain. Acta Neuropathol Commun 6:50. https:\/\/doi.org\/10.1186\/s40478-018-0552-y","journal-title":"Acta Neuropathol Commun"},{"key":"2318_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fpsyt.2011.00059","volume":"2","author":"PK Krishnamurthy","year":"2011","unstructured":"Krishnamurthy PK, Deng Y, Sigurdsson EM (2011) Mechanistic studies of antibody-mediated clearance of Tau aggregates using an ex vivo brain slice model. Front Psychiatry 2:59. https:\/\/doi.org\/10.3389\/fpsyt.2011.00059","journal-title":"Front Psychiatry"},{"key":"2318_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0192-x","volume":"12","author":"CE Leyns","year":"2017","unstructured":"Leyns CE, Holtzman DM (2017) Glial contributions to neurodegeneration in tauopathies. Mol Neurodegener 12:1\u201316","journal-title":"Mol Neurodegener"},{"key":"2318_CR23","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","volume":"136","author":"JL Molinuevo","year":"2018","unstructured":"Molinuevo JL, Ayton S, Batrla R, Bednar MM, Bittner T, Cummings J, Fagan AM, Hampel H, Mielke MM, Mikulskis A et al (2018) Current state of Alzheimer\u2019s fluid biomarkers. Acta Neuropathol 136:821\u2013853. https:\/\/doi.org\/10.1007\/s00401-018-1932-x","journal-title":"Acta Neuropathol"},{"key":"2318_CR24","doi-asserted-by":"publisher","first-page":"13211","DOI":"10.1038\/s41598-017-13581-z","volume":"7","author":"H Morrison","year":"2017","unstructured":"Morrison H, Young K, Qureshi M, Rowe RK, Lifshitz J (2017) Quantitative microglia analyses reveal diverse morphologic responses in the rat cortex after diffuse brain injury. Sci Rep 7:13211. https:\/\/doi.org\/10.1038\/s41598-017-13581-z","journal-title":"Sci Rep"},{"key":"2318_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"C Peng","year":"2020","unstructured":"Peng C, Trojanowski JQ, Lee VM (2020) Protein transmission in neurodegenerative disease. Nat Rev Neurol 16:199\u2013212. https:\/\/doi.org\/10.1038\/s41582-020-0333-7","journal-title":"Nat Rev Neurol"},{"key":"2318_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.trci.2018.10.007","volume":"4","author":"IA Qureshi","year":"2018","unstructured":"Qureshi IA, Tirucherai G, Ahlijanian MK, Kolaitis G, Bechtold C, Grundman M (2018) A randomized, single ascending dose study of intravenous BIIB092 in healthy participants. Alzheimers Dement (N Y) 4:746\u2013755. https:\/\/doi.org\/10.1016\/j.trci.2018.10.007","journal-title":"Alzheimers Dement (N Y)"},{"key":"2318_CR27","doi-asserted-by":"publisher","first-page":"105120","DOI":"10.1016\/j.nbd.2020.105120","volume":"146","author":"R Sopko","year":"2020","unstructured":"Sopko R, Golonzhka O, Arndt J, Quan C, Czerkowicz J, Cameron A, Smith B, Murugesan Y, Gibbons G, Kim SJ et al (2020) Characterization of tau binding by gosuranemab. Neurobiol Dis 146:105120. https:\/\/doi.org\/10.1016\/j.nbd.2020.105120","journal-title":"Neurobiol Dis"},{"key":"2318_CR28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00401-002-0569-x","volume":"104","author":"T Togo","year":"2002","unstructured":"Togo T, Dickson DW (2002) Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Acta Neuropathol 104:398\u2013402. https:\/\/doi.org\/10.1007\/s00401-002-0569-x","journal-title":"Acta Neuropathol"},{"issue":"477\u2013484","key":"2318_CR29","doi-asserted-by":"publisher","first-page":"e471","DOI":"10.1016\/j.jalz.2013.06.003","volume":"10","author":"JB Toledo","year":"2014","unstructured":"Toledo JB, Van Deerlin VM, Lee EB, Suh E, Baek Y, Robinson JL, Xie SX, McBride J, Wood EM, Schuck T et al (2014) A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimers Dement 10(477\u2013484):e471. https:\/\/doi.org\/10.1016\/j.jalz.2013.06.003","journal-title":"Alzheimers Dement"},{"key":"2318_CR30","first-page":"125","volume":"40","author":"T Wierzba-Bobrowicz","year":"2002","unstructured":"Wierzba-Bobrowicz T, Gwiazda E, Kosno-Kruszewska E, Lewandowska E, Lechowicz W, Bertrand E, Szpak GM, Schmidt-Sidor B (2002) Morphological analysis of active microglia\u2013rod and ramified microglia in human brains affected by some neurological diseases (SSPE, Alzheimer\u2019s disease and Wilson\u2019s disease). Folia Neuropathol 40:125\u2013131","journal-title":"Folia Neuropathol"},{"key":"2318_CR31","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12974-020-01907-0","volume":"17","author":"IOC Woollacott","year":"2020","unstructured":"Woollacott IOC, Toomey CE, Strand C, Courtney R, Benson BC, Rohrer JD, Lashley T (2020) Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration. J Neuroinflammation 17:234. https:\/\/doi.org\/10.1186\/s12974-020-01907-0","journal-title":"J Neuroinflammation"},{"key":"2318_CR32","doi-asserted-by":"publisher","first-page":"13110","DOI":"10.1523\/JNEUROSCI.2569-11.2011","volume":"31","author":"K Yamada","year":"2011","unstructured":"Yamada K, Cirrito JR, Stewart FR, Jiang H, Finn MB, Holmes BB, Binder LI, Mandelkow EM, Diamond MI, Lee VM et al (2011) In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J Neurosci 31:13110\u201313117. https:\/\/doi.org\/10.1523\/JNEUROSCI.2569-11.2011","journal-title":"J Neurosci"},{"key":"2318_CR33","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/jneurosci.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O\u2019Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N et al (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34:11929\u201311947. https:\/\/doi.org\/10.1523\/jneurosci.1860-14.2014","journal-title":"J Neurosci"},{"key":"2318_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1742-2094-9-247","volume":"9","author":"JM Ziebell","year":"2012","unstructured":"Ziebell JM, Taylor SE, Cao T, Harrison JL, Lifshitz J (2012) Rod microglia: elongation, alignment, and coupling to form trains across the somatosensory cortex after experimental diffuse brain injury. J Neuroinflammation 9:247. https:\/\/doi.org\/10.1186\/1742-2094-9-247","journal-title":"J Neuroinflammation"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-021-02318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-021-02318-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-021-02318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T13:05:14Z","timestamp":1625835914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-021-02318-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2318"],"URL":"https:\/\/doi.org\/10.1007\/s00401-021-02318-y","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]},"assertion":[{"value":"12 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"During the editing process, Biogen had the opportunity to review the manuscript. The authors had full editorial control of the manuscript and provided their final approval on all content.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}